2024-03-29T04:46:05Z
https://niigata-u.repo.nii.ac.jp/oai
oai:niigata-u.repo.nii.ac.jp:00015348
2022-12-15T03:47:07Z
453:456
471:537:538:1085
IgA腎症の発症の病因解明に関する研究 : IgA腎症扁桃リンパ球のHaemophilus parainfluenzae菌体外膜抗原に対する特異的免疫応答について
IgA腎症の発症の病因解明に関する研究 : IgA腎症扁桃リンパ球のHaemophilus parainfluenzae菌体外膜抗原に対する特異的免疫応答について
Study of Pathogenesis of IgA Nephropathy : Immune Response of Tonsillar Lymphocytes to Haemophilus parainfluenzae Outer Membrane Antigen in Patients with IgA Nephropathy
鈴木, 亨
下條, 文武
IgA nephropathy
Haemophilus parainfluenzae
outer membrane
T cell
B cell
IgA腎症
ヘモフィルス パラインフルエンザ
外膜
T細胞
B細胞
IgA nephropathy (IgAN) is characterized by the presence of IgA deposits, predominantly in the glomerular mesangium, and by mesangial proliferative glomerulonephritis (GN). Concerning its pathogenesis, several investigators have suggested that the deposited IgA is an antibody (Ab) to viral, bacterial or dietary antigens. Thus, the Ab is probably produced as part of the specific host immune response to various environmental antigens. Such reports strengthen the possibility of a relationship between mucosal immunity and the pathogenesis of IgAN. Nevertheless, attempts to isolate a specific IgA circulating immune complex associated antigen in patients with IgAN have been unsuccessful. We have shown that mucosal infection such as pharyngitis are often associated with the acute onset of IgAN. IgAN is, then, an immune complex disease that is caused by a poor mucosal immune response to environmental antigens to which the patient has been chronically exposed. We have observed previously that Haemophilus parainfluenzae (HP) is more commonly isolated from the pharynx of patients with IgAN than from those with other diseases.We have also identified the glomerular deposition of outer membranes of HP antigens (OMHP) and an increased serum concentration of IgA-Ab against OMHP in patients with IgAN. Furthermore, We have shown that patients with IgAN have a specific increase in the production of IgA-Ab against OMHP via polyclonal activation against these, with switching of production from one isotype to another, e.g. from IgM to IgA, and that a significant relationship between IgA-Ab against OMHP and renal lesions exists in patients with IgAN. On the basis of the above findings, we attempted to clarify the immune response between OMHP and lymphocytes in tonsils from patients with IgAN or other glomerular diseases (OGDs). We have shown that lymphocytes from patients with IgAN have a significantly higher stimulation index to OMHP (thymidine incorporation in tonsillar lymphocytes with OMHP/thymidine incorporation in unstimulated tonsillar lymphocytes) and a significantly higher level of IgA-Ab and IgA1-Ab against OMHP in culture supernatants than lymphocytes from OGDs. We have also found positive correlations between concentrations of IgA- and IgG- Abs, between IgA- and IgM-Abs, and between IgG- and IgM-Abs against OMHP after PMHP stimulation by measuring Abs against in supernatants from OMHP-stimulated lymphocytes. These results suggest that the immune response between OMHP and lymphocytes in tonsils plays a role in pathogenesis of IgAN.
新潟医学会
2000-07
jpn
departmental bulletin paper
http://hdl.handle.net/10191/49033
https://niigata-u.repo.nii.ac.jp/records/15348
AN00182415
00290440
新潟医学会雑誌
新潟医学会雑誌
114
7
255
263
https://niigata-u.repo.nii.ac.jp/record/15348/files/114(7)_255-263.pdf
application/pdf
1.4 MB
2019-08-07